iSTAR Medical iSTAR Medical iSTAR Medical

iSTAR Medical

Development of ophthalmic implants for glaucoma patients

iSTAR Medical was founded in 2011 and is a clinical-stage, medical technology company focused on developing novel ophthalmic implants for patients with glaucoma. iSTAR Medical’s product MINIject® is approved in Europe for treating glaucoma. In clinical trials, MINIject has been shown to provide safe, meaningful and sustained treatment to lower eye pressure for patients with primary, open-angle glaucoma.

Life Sciences

Visit website

Investment  details

Entry

2019

Staff

Location

Belgium

We value the support of investors and their representatives who understand our business. And that is clearly the case with Gimv. Having such ‘smart money’ at the table is priceless. As the CEO and management team, we wholeheartedly appreciate the support of investors like Gimv.

Michel Vanbrabant

CEO

Partnership Gimv Partnership Gimv Partnership Gimv

Partnership Gimv

Gimv supports iSTAR Medical to become the leading player in the field of Minimally Invasive Glaucoma Surgery (MIGS). When evaluating investment opportunities, Gimv always looks at the urgency of the need, and in the case of the iSTAR product, this was abundantly clear.